Farabi Pharmaceutical (XTEH:DFRB1) Net Margin %: 0.00% (As of . 20)


What is Farabi Pharmaceutical Net Margin %?

Farabi Pharmaceutical XTEH:DFRB1 Net Margin % is 0.00% as of . 20.

Net margin is calculated as Net Income divided by its Revenue. Farabi Pharmaceutical's Net Income for the three months ended in . 20 was IRR0.00 Mil. Farabi Pharmaceutical's Revenue for the three months ended in . 20 was IRR0.00 Mil. Therefore, Farabi Pharmaceutical's net margin for the quarter that ended in . 20 was 0.00%.

The historical rank and industry rank for Farabi Pharmaceutical's Net Margin % or its related term are showing as below:


XTEH:DFRB1's Net Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.69
* Ranked among companies with meaningful Net Margin % only.

Farabi Pharmaceutical  (XTEH:DFRB1) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Farabi Pharmaceutical Net Margin % Related Terms

Farabi Pharmaceutical Net Margin % Historical Data

* Premium members only.

The historical data trend for Farabi Pharmaceutical's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farabi Pharmaceutical Net Margin % Chart

Farabi Pharmaceutical Annual Data
Trend
Net Margin %

Farabi Pharmaceutical Quarterly Data
Net Margin %

XTEH:DFRB1 vs IMNPQ, INNV: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Farabi Pharmaceutical's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Farabi Pharmaceutical Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Farabi Pharmaceutical's Net Margin % distribution charts can be found below:

* The bar in red indicates where Farabi Pharmaceutical's Net Margin % falls into.


Farabi Pharmaceutical Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Farabi Pharmaceutical's Net Margin for the fiscal year that ended in . 20 is calculated as

Net Margin=Net Income (A: . 20 )/Revenue (A: . 20 )
=/
= %

Farabi Pharmaceutical's Net Margin for the quarter that ended in . 20 is calculated as

Net Margin=Net Income (Q: . 20 )/Revenue (Q: . 20 )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Farabi Pharmaceutical (XTEH:DFRB1) has a Net Margin % of 0.00% as of . 20. Net margin is the ratio of total net income to net sales. View historical data on Farabi Pharmaceutical and its competitors.
Is Farabi Pharmaceutical's Net Margin % too high?
Farabi Pharmaceutical's current Net Margin % is 0.00%.
How does Farabi Pharmaceutical's Net Margin % compare to IMNPQ and INNV?
Farabi Pharmaceutical's Net Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median Net Margin % is 5.69. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.69, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Farabi Pharmaceutical and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Farabi Pharmaceutical's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farabi Pharmaceutical stock overvalued right now?
Farabi Pharmaceutical (XTEH:DFRB1) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Farabi Pharmaceutical (XTEH:DFRB1), the current Net Margin % is 0.00% as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Farabi Pharmaceutical Business Description

Address South Kheradmand, No. 45, First Floor, Tehran, IRN, 1584853114
Farabi Pharmaceutical is a pharmaceutical company based in Iran. It produces various oral antibiotic-related and non-antibiotic products and dietary supplements. The company develops anti-migraine, antivirals, cholesterol, diabetic, cardiovascular, gastrointestinal, neuroleptics, anti-prostatic and anti-inflammatory and pain release drugs. It offers products in the form of tablet, capsule and suspensions which include Amoxicillin, Cefixime, Azithromycin, Ciprofloxacin, Nitroglycerin, Repaglinide, Orlistat, Domperidone, among others.